Evidence map›Paper›PMID 14724683›Full record

ReviewGene therapy2004

Gene intervention in ligament and tendon: current status, challenges, future directions.

K A Hildebrand, C B Frank, D A Hart

Abstract readReview
PubMed Publisher
In one paragraph

Review in Gene therapy, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Advanced Gene Therapy Strategies for the Repair of ACL Injuries.International journal of molecular sciences · 2022
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Tendinopathy: injury, repair, and current exploration.Drug design, development and therapy · 2018
    Review
  13. Review
  14. Article
  15. Review
  16. Biologics for tendon repair.Advanced drug delivery reviews · 2015
    Review
  17. Review
  18. Article
  19. The genetics of sports injuries and athletic performance.Muscles, ligaments and tendons journal · 2013
    Review
  20. Bioreactor design for tendon/ligament engineering.Tissue engineering. Part B, Reviews · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

K A HildebrandMcCaig Centre for Joint Injury and Arthritis Research, University of Calgary, Calgary, AB, Canada.
C B Frank
D A Hart

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ligament and tendon injuries are common clinical problems. Healing of these tissues occurs, but their properties do not return to normal. This predisposes to recurrent injuries, instability and arthritis, loss of motion and weakness. Gene therapy offers a novel approach to the repair of ligaments and tendons. Introduction of genes into ligaments and tendons using vectors has been successful. Marker genes and therapeutic genes have been introduced into both tissues with evidence of corresponding functional alterations. In addition, gene transfer has been used to manipulate the healing environment, opening the possibility of gene transfer to investigate ligament and tendon development and homeostasis, in addition to using this technology therapeutically. Several factors modulate the 'success' of gene transfer in these tissues.

Indexed as

AnimalsFeasibility StudiesGenetic TherapyGene Transfer TechniquesHumansLigaments, ArticularTendon Injuries

Identifiers

PMID14724683

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.